AXQ-15721-92388
3 vaccinations
9 coded responses
39 check-ins
9 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 190 / PA
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-18
Survey response — day 0, dose 1MedDRA: Fatigue — Feeling: Good · Fatigue or tirednessFree text: I worked overnight before getting the shot, so the tiredness is probably normalMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: These were worst in the 10-17 hrs post-injection. I am currently 32h post-injectiononMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-10
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Axillary lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-10-01
Dose 3 — Pfizer-BioNTech
- 2021-10-01
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain, Oedema peripheral — Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Axillary pain and mild swelling on the side of the injectionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Axillary swellingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral — Feeling: Good · Site: Pain, Redness · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolFree text: Axillary swellingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral — Feeling: Good · Site: PainFree text: Axillary swelling improvingMedDRA releases: 2024-11 · check-in free text available
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-15
- 2021-10-22
-
2021-10-29
Survey response — day 28, dose 3MedDRA: Cough, Nasal congestion, SARS-CoV-2 test negative, Upper respiratory tract infection, Viral upper respiratory tract infection — Feeling: GoodFree text: URI -- nasal congestion, cough. Multiple covid pcr tests negative. Likely other viral URI, now resolvingMedDRA releases: 2024-11 · check-in free text available
- 2021-11-07
- 2021-11-12
- 2021-12-31
- 2022-04-01
-
2022-10-01
Survey response — 12 months, dose 3MedDRA: COVID-19, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend schoolFree text: Had covid infection may 2022 Currently have a non-covid URIMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): I worked overnight before getting the shot, so the tiredness is probably normal
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): These were worst in the 10-17 hrs post-injection. I am currently 32h post-injectionon
Systemic reaction (other): Axillary lymphadenopathy
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Axillary pain and mild swelling on the side of the injection
Systemic reaction (other): Axillary swelling
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Axillary swelling
Systemic reaction (other): Axillary swelling improving
Release 10 — day 28, dose 3
Symptoms: URI -- nasal congestion, cough. Multiple covid pcr tests negative. Likely other viral URI, now resolving
Release 12 — 12 months, dose 3
Symptoms: Had covid infection may 2022 Currently have a non-covid URI
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Viral upper respiratory tract infection | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release